Measure and Instrument Development and Support (MIDS 2)

The Centers for Medicare and Medicaid Services established a Master IDIQ for Measure and Instrument Development and Support (MIDS) on September 4, 2018, with ordering authority extending through September 3, 2028—approximately two years and one month of vehicle lifecycle remaining. The vehicle funds clinical quality measure development and maintenance aligned with CMS's Measures Management System Blueprint, supporting quality reporting programs across Medicare and Medicaid.

Ordering activity accelerated significantly in 2024, with 20 task orders awarded that year compared to single-digit annual volumes in prior years; three orders have been issued year-to-date through mid-August 2025. The vehicle has obligated $785.9 million of its $1.06 billion combined potential value across 60 task orders, indicating 74 percent drawdown. The most recent award (August 13, 2025) carries a ceiling of $2.7 million, though multiple 2024 orders exceeded $30 million in potential value, with one reaching $51.8 million.

Task-order work spans quality measure development, maintenance, and implementation across clinical settings including hospital quality reporting, post-acute care, home health, skilled nursing facilities, end-stage renal disease, behavioral health, and physician-level cost measures. Orders also fund website and public reporting system support, data validation, training, and stakeholder engagement.

Mathematica Inc., Acumen LLC, and Yale New Haven Health Services Corporation dominate the prime contractor base, collectively holding 37 percent of awarded orders and 62 percent of combined potential value. Mathematica accounts for 10 orders worth $149.6 million; Yale New Haven holds 6 orders worth $200.5 million. The remaining 15 awardees include Health Services Advisory Group, General Dynamics Information Technology, and Lantana Consulting Group, with a long tail of smaller firms. All 60 task orders fund CMS alone, with no cross-agency activity.

The set-aside mix is predominantly unrestricted: 87 percent of orders carry no set-aside designation. Small business awards account for 13 percent of orders, spread across eight task orders. Pricing is mixed, with Cost Plus Fixed Fee dominating, but Firm Fixed Price and Time and Materials also present. Durations typically run three to five years, with several 2024 orders completing in 2029.

The MIDS supports the development and use of clinical quality measures which remains a critical healthcare priority and the tool of choice for improving quality of care at the national, community and facility levels. The MIDS Indefinite Delivery, Indefinite Quantity (IDIQ) contract provides a vehicle to objectively evaluate and promote quality of care within the Federal quality reporting programs by aligning with the Measures Management System (MMS) Blueprint, a comprehensive and structured process for developing and maintaining evidence-based clinical quality measures.